Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

女性医療診断の世界市場予測(~2021):出生前検査、ダウン症候群検査、HPV検査、受胎能試験、妊娠テスト、 尿路感染症検査、骨粗鬆症検査、乳がん検査、子宮頸がん検査、卵巣がん検査

◆タイトル:Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021
◆商品コード:MAM-MD-4774
◆調査・発行会社:MarketsandMarkets
◆発行日:2016年11月25日
◆ページ数:296
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、女性医療診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、用途別分析、需要先別分析、地域別分析、女性医療診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. This market is mainly driven by the increased adoption of point-of-care & rapid diagnostic tests, growth in the number of private diagnostic centers, high prevalence of infectious diseases in women, rising incidence of chronic & lifestyle-related disorders in women and increasing awareness about fertility testing in women & initiatives taken by government and health organizations. Moreover, improving healthcare infrastructure in emerging markets and growing number of regulatory approvals for immunoassay techniques further provide significant growth opportunities for market players in the women health diagnostics market. However, high cost of diagnostic imaging systems & procedures and shortage of skilled laboratory technicians are the major factors hampering the growth of this market.
In this report, the global women’s health diagnostics market is segmented on the basis of applications, and end users. On the basis of application, the market is segmented into various segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. On the basis of end user, the global women health diagnostics is segmented into three segments, namely, hospital and clinics, home healthcare, and diagnostic & imaging centers.

In 2015, the breast cancer testing segment accounted for the largest share of the market. However, the prenatal genetic screening and carrier testing segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors such as the growing number of doctors offering genetic screening tests to pregnant women and growing awareness about these tests.

Geographically, the women’s health diagnostics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. Asia-Pacific represented the fastest-growing region for the women health diagnostics market, primarily due to improving healthcare infrastructure, growing per capita income, growing awareness among women regarding various health disorders, and rising focus of key market players on this region.

The global women’s health diagnostics market is a mature market and characterized by the presence of number of players. This industry is witnessing an increasing number of acquisitions, product launches and alliances such as partnerships, agreements, and collaborations between players offering better women health diagnostics solutions. Major players in the global women’s health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

【レポートの目次】

1 Introduction (Page No. – 22)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 26)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 34)

4 Premium Insights (Page No. – 37)
4.1 Women’s Health Diagnostics: Market Overview
4.2 Asia-Pacific: Pregnancy and Fertility Testing Market, By Product Type (2015)
4.3 Geographic Snapshot of the Women’s Health Diagnostics Market
4.4 Geograpgic Mix: Women’s Health Diagnostics Market
4.5 Women’s Health Diagnostics Market: Developed vs Developing Markets

5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Key Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 High Prevalence of Infectious Diseases in Women
5.2.1.2 Rising Incidence of Chronic and Lifestyle-Related Disorders in Women
5.2.1.3 Increasing Awareness About Fertility Testing in Women and IniTIAtives Taken By Government and Health Organizations
5.2.1.4 Increased Adoption of Point-Of-Care and Rapid Diagnostic Tests
5.2.1.5 Growth in the Number of Private Diagnostic and Imaging Centers
5.2.1.6 Public-Private Partnerships to Enhance the Infrastructure of Diagnostic Imaging Centers
5.2.2 Key Market Restraints
5.2.2.1 High Cost of Diagnostic Imaging Systems and Procedures
5.2.2.2 Shortage of Skilled Laboratory Technicians
5.2.3 Key Market Opportunities
5.2.3.1 Improving Healthcare Infrastructure in Emerging Markets
5.2.3.2 Growing Number of Regulatory Approvals for Immunoassay Diagnostic Techniques
5.2.4 Key Market Challenges
5.2.4.1 Stringent Regulatory Guidelines
5.2.4.2 Increasing Adoption of Refurbished Diagnostic Imaging Systems

6 Industry Insights (Page No. – 53)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Focus on Microfluidics- and Nanotechnology-Based POC Devices for Diagnostics
6.2.1.1 Microfluidics-Based Lab-On-A-Chip (LoC) Devices for Laboratory Testing
6.2.1.2 Evolution of Paper-Based Microfluidic Poc Diagnostic Devices
6.2.2 Rising Focus of Market Players on Pregnancy and Fertility Issues in Emerging Regions
6.3 Clinical Trials Assessment for Breast Cancer Diagnostics

7 Women’s Health Diagnostics Market, By Application (Page No. – 58)
7.1 Introduction
7.2 Osteoporosis Testing
7.2.1 Bone Densitometry
7.2.2 in Vitro Blood Tests
7.3 Breast Cancer Testing
7.3.1 Mammography
7.3.2 Breast Cancer Tumor Marker Tests
7.3.3 Blood Chemistries and Blood Cell Count Tests
7.3.4 Biopsies
7.3.5 Other Diagnostic Imaging Tests
7.4 Ovarian Cancer Testing
7.4.1 Ovarian Cancer Tumor Marker Tests
7.4.2 Diagnostic Imaging Tests
7.4.3 Other Tests
7.5 Cervical Cancer Testing
7.5.1 PAP Smear
7.5.2 HPV Testing
7.6 Pregnancy and Fertility Testing
7.6.1 Lab-Based Testing
7.6.2 Pregnancy Testing and Ovulation Prediction Kits
7.6.3 Fertility Monitors
7.7 Prenatal Genetic Screening and Carrier Testing
7.7.1 Cystic Fibrosis
7.7.2 Down Syndrome and Edwards Syndrome
7.7.3 Torch Infections
7.7.4 Other Diseases
7.8 Infectious Disease Testing
7.8.1 MRSA Testing
7.8.2 Urinary Tract Infection Testing (Vaginal Ph & Vaginitis)
7.8.3 HEPAtitis Testing
7.8.4 Tuberculosis Testing
7.8.5 Other Infectious Diseases
7.9 Sexually Transmitted Disease Testing
7.9.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Testing
7.9.2 HIV Testing
7.9.3 Other Sexually Transmitted Diseases
7.10 Ultrasound Tests
7.10.1 Breast Imaging
7.10.2 OB/GYN Imaging

8 Women’s Health Diagnostics Market, By End User (Page No. – 108)
8.1 Introduction
8.2 Hospitals and Clinics
8.3 Diagnostic and Imaging Centers
8.4 Home Care

9 Women’s Health Diagnostics Market, By Region (Page No. – 115)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific
9.5 RoW
9.5.1 Latin America
9.5.2 Middle East & Africa

10 Competitive Landscape (Page No. – 232)
10.1 Overview
10.2 Strategic Benchmarking
10.3 Competitive Situations and Trends
10.3.1 Product Launches
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Acquisitions
10.3.4 Regulatory Approvals

11 Company Profiles (Page No. – 241)
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Siemens AG
11.2 Quest Diagnostics Inc.
11.3 Hologic, Inc.
11.4 F. Hoffmann-La Roche AG
11.5 Perkinelmer Inc.
11.6 Alere Inc.
11.7 GE Healthcare
11.8 Becton, Dickinson and Company
11.9 Abbott Laboratories
11.10 Biomérieux SA
11.11 Koninklijke Philips N.V.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 279)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports

List of Tables (265 Tables)

Table 1 Rising Incidence of Chronic and Lifestyle-Related Disorders in Women to Drive Market Growth
Table 2 High Cost of Diagnostic Imaging Systems and Procedures Affecting the Rate of Adoption in Emerging Markets
Table 3 Improving Healthcare Infrastructure in Emerging Markets to Play A Major Role in the Growth of the Women’s Health Diagnostics Market
Table 4 Stringent Regulatory Guidelines Pose A Challenge for Diagnostic Device Manufacturers
Table 5 Women’s Health Diagnostics Market: Product Portfolio Analysis
Table 6 Global Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 7 Global Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 8 Global Osteoporosis Testing Market Size, By Country, 2014-2021 (USD Million)
Table 9 Global Bone Densitometry Market Size, By Country, 2014-2021 (USD Million)
Table 10 Global in Vitro Blood Tests Market Size, By Country, 2014-2021 (USD Million)
Table 11 Global Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 12 Global Breast Cancer Testing Market Size, By Country, 2014-2021 (USD Million)
Table 13 Global Mammography Systems Market Size, By Country, 2014-2021 (USD Million)
Table 14 Global Breast Cancer Tumor Marker Tests Market Size, By Country, 2014-2021 (USD Million)
Table 15 Global Blood Chemistries and Blood Cell Count Tests Market Size, By Country, 2014-2021 (USD Million)
Table 16 Global Biopsies Market Size, By Country, 2014-2021 (USD Million)
Table 17 Global Other Diagnostic Imaging Tests Market Size, By Country, 2014-2021 (USD Million)
Table 18 Global Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 19 Global Ovarian Cancer Testing Market Size, By Country, 2014-2021 (USD Million)
Table 20 Global Ovarian Cancer Tumor Marker Tests Market Size, By Country, 2014-2021 (USD Million)
Table 21 Global Diagnostic Imaging Tests Market Size, By Country, 2014-2021 (USD Million)
Table 22 Global Other Ovarian Cancer Tests Market Size, By Country/Region, 2014-2021 (USD Million)
Table 23 Global Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 24 Global Cervical Cancer Testing Market Size, By Country, 2014-2021 (USD Million)
Table 25 Global PAP Smear Market Size, By Country, 2014-2021 (USD Million)
Table 26 Global HPV Testing Market Size, By Country, 2014-2021 (USD Million)
Table 27 Global Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 28 Global Pregnancy and Fertility Testing Market Size, By Country, 2014-2021 (USD Million)
Table 29 Global Lab-Based Testing Market Size, By Country, 2014-2021 (USD Million)
Table 30 Global Pregnancy and Ovulation Prediction Kits Testing Market Size, By Country, 2014-2021 (USD Million)
Table 31 Global Fertility Monitors Market Size, By Country, 2014-2021 (USD Million)
Table 32 Global Prenatal Genetic Screening and Carrier Testing Market Size, By Type, 2014-2021 (USD Million)
Table 33 Global Prenatal Genetic Screening and Carrier Testing Market Size, By Country, 2014-2021 (USD Million)
Table 34 Global Cystic Fibrosis Market Size, By Country, 2014-2021 (USD Million)
Table 35 Global Down Syndrome and Edwards Syndrome Market Size, By Country, 2014-2021 (USD Million)
Table 36 Global Torch Infections Market Size, By Country, 2014-2021 (USD Million)
Table 37 Global Other Diseases Market Size, By Country, 2014-2021 (USD Million)
Table 38 Global Infectious Disease Testing Market Size, By Type, 2014-2021 (USD Million)
Table 39 Global Infectious Disease Testing Market Size, By Country, 2014-2021 (USD Million)
Table 40 Global MRSA Testing Market Size, By Country, 2014-2021 (USD Million)
Table 41 Global Urinary Tract Infection Testing Market Size, By Country, 2014-2021 (USD Million)
Table 42 Global HEPAtitis Testing Market Size, By Country, 2014-2021 (USD Million)
Table 43 Global Tuberculosis Testing Market Size, By Country, 2014-2021 (USD Million)
Table 44 Global Other Infectious Disease Testing Market Size, By Country, 2014-2021 (USD Million)
Table 45 Global Sexually Transmitted Disease Testing Market Size, By Type, 2014-2021 (USD Million)
Table 46 Global Sexually Transmitted Disease Testing Market Size, By Country, 2014-2021 (USD Million)
Table 47 Global CT/NG Testing Market Size, By Country, 2014-2021 (USD Million)
Table 48 Global HIV Testing Market Size, By Country, 2014-2021 (USD Million)
Table 49 Global Other Sexually Transmitted Diseases Market Size, By Country, 2014-2021 (USD Million)
Table 50 Global Ultrasound Tests Market Size, By Type, 2014-2021 (USD Million)
Table 51 Global Ultrasound Tests Market Size, By Country, 2014-2021 (USD Million)
Table 52 Global Breast Imaging Market Size, By Country, 2014-2021 (USD Million)
Table 53 Global OB/GYN Market Size, By Country, 2014-2021 (USD Million)
Table 54 Global Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 55 Global Women’s Health Diagnostics Market Size for Hospitals and Clinics, By Country, 2014–2021 (USD Million)
Table 56 Global Women’s Health Diagnostics Market Size for Diagnostic and Imaging Centers, By Country, 2014–2021 (USD Million)
Table 57 Global Women’s Health Diagnostics Market Size for Home Care, By Country, 2014–2021 (USD Million)
Table 58 Women’s Health Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 59 North America: Women’s Health Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 60 North America: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 61 North America: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 62 North America: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 63 North America: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 64 North America: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 65 North America: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 66 North America: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 67 North America: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 68 North America: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 69 North America: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 70 North America: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 71 U.S.: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 72 U.S.: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 73 U.S.: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 74 U.S.: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 75 U.S.: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 76 U.S.: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 77 U.S.: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 78 U.S.: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 79 U.S.: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 80 U.S.: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 81 U.S.: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 82 Canada: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 83 Canada: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 84 Canada: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 85 Canada: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 86 Canada: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 87 Canada: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 88 Canada: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 89 Canada: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 90 Canada: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 91 Canada: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 92 Canada: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 93 Europe: Women’s Health Diagnostics Market Size, By Country, 2014-2021(USD Million)
Table 94 Europe: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 95 Europe: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 96 Europe: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 97 Europe: Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 98 Europe: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 99 Europe: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 100 Europe: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 101 Europe: Prenatal Genetic and Carrier Testing Market Size, By Disease Type,2014-2021 (USD Million)
Table 102 Europe: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 103 Europe: Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 104 Europe: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 105 Germany: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 106 Germany: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 107 Germany: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 108 Germany: Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 109 Germany: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 110 Germany: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 111 Germany: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 112 Germany: Prenatal Genetic and Carrier Testing Market Size, By Disease Type,2014-2021 (USD Million)
Table 113 Germany: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 114 Germany: Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 115 Germany: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 116 U.K.: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 117 U.K: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 118 U.K: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 119 U.K: Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 120 U.K: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 121 U.K: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 122 U.K: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 123 U.K: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014-2021 (USD Million)
Table 124 U.K: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 125 U.K: Ovarian Cancer Testing Market Size, By Type,2014-2021 (USD Million)
Table 126 U.K: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 127 France: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 128 France: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 129 France: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 130 France : Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 131 France: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 132 France: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 133 France: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 134 France: Prenatal Genetic and Carrier Testing Market Size, By Disease Type,2014-2021 (USD Million)
Table 135 France: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 136 France: Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 137 France: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 138 Italy : Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 139 Italy: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 140 Italy: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 141 Italy : Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 142 Italy: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 143 Italy: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 144 Italy: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 145 Italy: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014-2021 (USD Million)
Table 146 Italy: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 147 Italy: Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 148 Italy: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 149 Spain: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 150 Spain: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 151 Spain: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 152 Spain: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 153 Spain : Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 154 Spain : Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 155 Spain : Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 156 Spain : Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 157 Spain : Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 158 Spain : Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 159 Spain : Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 160 RoE: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 161 RoE: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 162 RoE: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 163 RoE: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 164 RoE: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 165 RoE: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 166 RoE: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 167 RoE: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 168 RoE: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 169 RoE: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 170 RoE: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 171 APAC: Women’s Health Diagnostics Market Size, By Country, 2014–2021(USD Million)
Table 172 APAC: Women’s Health Diagnostics Market Size, By Application, 2014–2021(USD Million)
Table 173 APAC: Breast Cancer Testing, By Type, (USD Million)
Table 174 APAC: Osteoporosis Testing, By Type, 2014–2021 (USD Million)
Table 175 APAC: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 176 APAC: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 177 APAC: Ultrasound Market Size, By Application, 2014–2021 (USD Million)
Table 178 APAC: Sexually Transmitted Diseases Market Size, By Disease Type, 2014–2021 (USD Million)
Table 179 APAC: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 180 APAC: Cervical Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 181 APAC: Ovarian Cancer Market Size, By Testing, 2014–2021 (USD Million)
Table 182 APAC: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 183 Japan: Women’s Health Diagnostics Market Size, By Application, 2014–2021(USD Million)
Table 184 Japan: Breast Cancer Testing, By Type, 2014–2021 (USD Million)
Table 185 Japan: Osteoporosis Testing, By Type, 2014–2021 (USD Million)
Table 186 Japan: Infectious Disease Testing Market Size, By Disease, 2014–2021, (USD Million)
Table 187 Japan: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021, (USD Million)
Table 188 Japan: Ultrasound Market Size, By Application, 2014–2021 (USD Million)
Table 189 Japan: Sexually Transmitted Diseases Market Size, By Disease Type, 2014–2021 (USD Million)
Table 190 Japan: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 191 Japan: Cervical Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 192 Japan: Ovarian Cancer Market Size, By Testing, 2014–2021 (USD Million)
Table 193 Japan: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 194 China: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 195 China: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 196 China: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 197 China: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 198 China: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 199 China: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 200 China: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 201 China: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 202 China: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 203 China: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 204 China: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 205 India: Women’s Health Diagnostics Market Size, By Application, 2014–2021(USD Million)
Table 206 India: Breast Cancer Testing, By Type, 2014–2021 (USD Million)
Table 207 India: Osteoporosis Testing, By Type, 2014–2021 (USD Million)
Table 208 India: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 209 India: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 210 India: Ultrasound Market Size, By Application, 2014–2021 (USD Million)
Table 211 India: Sexually Transmitted Diseases Market Size, By Disease Type, 2014–2021 (USD Million)
Table 212 India: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 213 India: Cervical Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 214 India: Ovarian Cancer Market Size, By Testing, 2014–2021 (USD Million)
Table 215 India: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 216 RoAPAC: Women’s Health Diagnostics Market Size, By Application, 2014–2021(USD Million)
Table 217 RoAPAC: Breast Cancer Testing, By Type, (USD Million)
Table 218 RoAPAC: Osteoporosis Testing, By Type, 2014–2021 (USD Million)
Table 219 RoAPAC: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 220 RoAPAC: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021, (USD Million)
Table 221 RoAPAC: Ultrasound Market Size, By Application, 2014–2021 (USD Million)
Table 222 RoAPAC: Sexually Transmitted Diseases Market Size, By Disease Type, 2014–2021 (USD Million)
Table 223 RoAPAC: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 224 RoAPAC: Cervical Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 225 RoAPAC: Ovarian Cancer Market Size, By Testing, 2014–2021, (USD Million)
Table 226 RoAPAC: Women’s Health Diagnostics Market Size, By End User (USD Million)
Table 227 RoW: Women’s Health Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 228 RoW: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 229 RoW: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 230 RoW: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 231 RoW: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 232 RoW: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 233 RoW: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 234 RoW: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 235 RoW: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 236 RoW: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 237 RoW: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 238 RoW: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 239 Latin America: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 240 Latin America: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 241 Latin America: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 242 Latin America: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 243 Latin America: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 244 Latin America: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 245 Latin America: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 246 Latin America: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 247 Latin America: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 248 Latin America: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 249 Latin America: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 250 Middle East & Africa: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 251 Middle East & Africa: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 252 Middle East & Africa: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 253 Middle East & Africa: Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 254 Middle East & Africa: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 255 Middle East & Africa: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 256 Middle East & Africa: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 257 Middle East & Africa: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014-2021 (USD Million)
Table 258 Middle East & Africa: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 259 Middle East & Africa: Ovarian Cancer Market Size, By Type, 2014-2021 (USD Million)
Table 260 Middle East & Africa: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 261 Growth Strategy Matrix (2013–2016)
Table 262 Product Launches, 2013–2016
Table 263 Agreements, Partnerships, and Collaborations, 2013–2016
Table 264 Acquisitions, 2013–2016
Table 265 Regulatory Approvals, 2013–2016


List of Figures (37 Figures)

Figure 1 Global Women’s Health Diagnostics Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Women’s Health Diagnostics Market, By Application, 2016 vs 2021
Figure 7 Women’s Health Diagnostics Market, By End User, 2016 vs 2021
Figure 8 Geographic Snapshot: Women’s Health Diagnostics Market
Figure 9 High Prevalence of Infectious Diseases in Women and Rising Incidence of Chronic and Lifestyle-Related Disorders in Women are Driving Growth in the Women’s Health Diagnostics Market
Figure 10 Pregnancy Testing and Ovulation Prediction Kits Segment Accounted for the Largest Share of the Asia-Pacific Pregnancy and Fertility Testing Market in 2015
Figure 11 The U.S. Commanded the Largest Share of the Women’s Health Diagnostics Market in 2015
Figure 12 APAC to Witness the Highest Growth Rate During the Forecast Period
Figure 13 Developing Markets to Register Higher Growth Rates During the Forecast Period
Figure 14 Women’s Health Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Clinical Studies for Breast Cancer Diagnostic Devices (2013-2016)
Figure 16 Breast Cancer Segment to Dominate the Market in 2016
Figure 17 Mammography Segment to Dominate the Market During the Forecast Period
Figure 18 Urinary Tract Infections Testing Segment to Dominate the Market in 2016
Figure 19 The Hospitals & Clinics End-User Segment Will Continue to Dominate the Global Women’s Health Diagnostics Market in 2021
Figure 20 North America: Women’s Health Diagnostics Market Snapshot
Figure 21 Europe: Women’s Health Diagnostics Market Snapshot
Figure 22 Asia-Pacific: Women’s Health Diagnostics Market Snapshot
Figure 23 Product Launch—Key Growth Strategy Adopted By Market Players From 2013 to September 2016
Figure 24 List of New Product Launches By Key Players in the Market From 2014 - 2016
Figure 25 Key Acquisitions: Women’s Health Diagnostics Market (2014–2016)
Figure 26 Battle for Market Share: Product Launch Accounted for the Largest Share During 2013 to 2016
Figure 27 Company Snapshot: Siemens AG
Figure 28 Company Snapshot: Quest Diagnostics Inc.
Figure 29 Company Snapshot: Hologic, Inc.
Figure 30 Company Snapshot: F. Hoffmann-La Roche AG
Figure 31 Company Snapshot: Perkinelmer Inc.
Figure 32 Company Snapshot: Alere Inc.
Figure 33 Company Snapshot: GE Healthcare
Figure 34 Company Snapshot: Becton, Dickinson and Company
Figure 35 Company Snapshot: Abbott Laboratories
Figure 36 Company Snapshot: Biomérieux SA
Figure 37 Company Snapshot: Koninklijke Philips N.V.

【レポートのキーワード】

女性医療診断、出生前検査、ダウン症候群検査、HPV検査、受胎能試験、妊娠テスト、 尿路感染症検査、骨粗鬆症検査、乳がん検査、子宮頸がん検査、卵巣がん検査

★調査レポート[女性医療診断の世界市場予測(~2021):出生前検査、ダウン症候群検査、HPV検査、受胎能試験、妊娠テスト、 尿路感染症検査、骨粗鬆症検査、乳がん検査、子宮頸がん検査、卵巣がん検査] ( Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021 / MAM-MD-4774) 販売に関する免責事項
[女性医療診断の世界市場予測(~2021):出生前検査、ダウン症候群検査、HPV検査、受胎能試験、妊娠テスト、 尿路感染症検査、骨粗鬆症検査、乳がん検査、子宮頸がん検査、卵巣がん検査] ( Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021 / MAM-MD-4774) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆